-
Nat Med: Liquid biopsy can accurately detect early kidney cancer
Time of Update: 2020-07-13
Kidney cancer is a common malignant tumor in urology, the incidence rate accounts for 2% to 3% of adult malignant tumors, although there are many symptoms of kidney cancer, but the diagnosis of kid
-
J Immuno Cancer: A Comparative Analysis of Phase III Clinical Trials for The Treatment of Head and Neck Squamous Cell Carcinoma Patients with Anti-PD1 Single Drug
Time of Update: 2020-07-13
Two Phase III clinical trials (CheckMate 141 and KEYNOTE 040) have independently demonstrated that the total lifetime (OS) of patients with failed platinum-based treatment can be improved with anti-
-
Cell: Seize the cancer 'metabolic weakness'! Real-time metabolic tracking and fat-free diet, good efficacy of tumor diagnosis and treatment
Time of Update: 2020-07-13
Often, cancer cells rely heavily on breaking down fat to promote their own growth and spread A new study has found that surgical "iKnife" can capture this weakness of cancer cells, and then use a co
-
Professor Liu Jian: China's biosimilardrugs meet international standards to meet the affordable drug needs of breast cancer patients
Time of Update: 2020-07-13
Breast cancer is the highest incidence of malignant tumors in women, the 5-year survival rate of about 70% to 90%, is also the number one cause of cancer death in women HER2-positive breast cancer
-
J Otolaryngol Head Neck Surg: Preoperative immunonutrition helps reduce complications after recurrent head and neck squamous cell carcinoma patients
Time of Update: 2020-07-13
Because radiotherapy is not conducive to wound healing, patients with recurrent head and neck squamous cell carcinoma who underwent rescue surgery are at high risk of postoperative complications Mal
-
Guangdong releases expert consensus on thyroid cancer genetic testing and clinical application for the first time
Time of Update: 2020-07-13
cell molecular diagnostic center staff is cutting specimens to do genetic testing hospital for Sun Yat-sen Memorial Hospital of Zhongshan University, said on the 22nd, by the hospital's directo
-
AACR 2020: NK Cell Therapy ACE1702 shows positive preclinical data
Time of Update: 2020-07-13
Acepodia is a biotechnology company dedicated to the development of cancer immuno therapy, ace1702 is a natural killer cell (NK cell) therapy, is being developed to treat HER2-positive solid tumors
-
FDA Approves Clinical Trial sized With Anti-Tumor Drug PI3K Alpha Inhibitor CYH33
Time of Update: 2020-07-13
In January 2018, CYH33, a new anti-tumor class 1 drug jointly developed by the Shanghai Institute of Pharmaceutical Research of the Chinese Academy of Sciences and Shanghai Haihe Pharmaceutical Rese
-
Nat Commun: Xiamen University Deng early summer team: NOTCH1 activation promotes the formation of triple negative breast cancer
Time of Update: 2020-07-13
Carriers of the BRCA1 mutation have a higher risk of developing triple-negative breast cancer (TNBC), a refractive disease that does not respond to current clinical targeted therapies using the
-
FDA approves dual-switch CAR-T cell therapy into clinical
Time of Update: 2020-07-13
Currently, CAR-T treatment has been successful in some blood tumors, but in fact, cytokine release syndrome (CRS) has been regarded as the biggest impediment to CAR-T cell therapy Although the d
-
Near-infrared immunotherapy (NIR-PIT): The dawn of the treatment of malignant pleural mesothelioma
Time of Update: 2020-07-13
Malignant pleural mesothelioma (MPM) is a rare tumor that affects the lining of the lung MPM rarely spreads to other parts of the body, but usually the patient is diagnosed with a terminal condition
-
Int J Clin Oncol: Safe and effective ness of carplatinum or cytoxisia monotomatherapy for local advanced head and neck cancer patients who cannot receive cisplatin treatment
Time of Update: 2020-07-13
Head and neck local late-stage squamous cell carcinoma (LASCCHN) usually uses cisplatin-based radiotherapy unless the patient is elderly or has kidney, heart, or nerve dysfunction This study compare
-
Cancer: Anti-cancer "new weapon"! Vitamin D could provide a 'protective umbrella' for the hottest cancer treatments
Time of Update: 2020-07-13
Cancer immunotherapy therapy has been hailed as the third revolution in cancer treatment As the hottest form of cancer treatment, it does not rely on drugs to kill cancer cells, but on the human b
-
J Clin Oncol: s18 F. fluorodeoxyglucose positron emission tomography scan/computer tomography on the stages of head and neck cancer and negative predictive value and surgical effects on the N0 neck
Time of Update: 2020-07-13
The purpose of this study is to determine the negative prediction (NPV) of the clinical N0 neck based on the positive electron emission tomography (PET)/computertomic tomography (CT) on the basis of
-
Sci TransL Med: An analytical method to improve the sensitivity of ctDNA sequencing!
Time of Update: 2020-07-13
The dna (ctDNA) of the source of circulating tumors can be used to monitor cancer dynamics without invasiveness CtDNA testing can be challenging for patients with small volumes of small plasma or sm
-
Science Signal: Rac1 does not rely on PI3K and GTPase-mediated MET-driven anchornon cell growth
Time of Update: 2020-07-13
In cancer, the common receptor tyrosine kinase (PTKs) is expressed or mutated, and PTKs are involved in driving tumor growth and metastasis In modern PTK signaling models (including MET), downstream
-
Another "broad spectrum" cancer drug approved: NICE approves Rozlytrek for all solid tumors used to treat NTRK gene fusion
Time of Update: 2020-07-13
The National Institutes of Health and Care Excellence ,NICE on Thursday released a draft final guidelines recommending the use of Roche's ALK inhibitor, Rozlytinib, through the Cancer Drug Fund (C
-
Cold Spring Harb Mol Case Stud: Bioinformatics uses RNA sequencing to guide personalized drug prescriptionmethods for stomach cancer
Time of Update: 2020-07-13
Immunotherapy is the latest treatment for stomach cancer, however, patients' responses to treatment are often unpredictable and require tailor-made treatments and drug prescriptions , researchers at
-
Chinese experts take the lead in proposing a predictive model of recurrence of thymus tumors to solve the world's medical problems
Time of Update: 2020-07-13
Do patients with thymus tumors need to undergo complementary therapy after surgery? What should be the frequency of scientific follow-up? Reporters learned on the 17th, China's 15 provinces and auto
-
Journal of Cell Science: University of Southern California study shows that semi-lactose can help destroy cancer cells
Time of Update: 2020-07-13
Introduction: Like all cells in the body, cancer cells need to metabolize glucose to promote their proliferation and growth In particular, cancer cells infinite proliferation, easy metastasis charac
